MedPath

PROBIOTICS (GOOD BACTERIA) TO PREVENT JAUNDICE IN SICK NEWBORN BABIES

Phase 2
Conditions
Health Condition 1: P599- Neonatal jaundice, unspecified
Registration Number
CTRI/2022/10/046339
Lead Sponsor
SRINIVAS MURKI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

LATE PRETERM BABIES(34-37 )WEEKS

INFANT OF DIABETIC MOTHERS

INTRAUTERINE GROWTH RESTRICTED BABIES

Exclusion Criteria

JAUNDICE ON DAY 1

MAJOR CONGENITAL MALFORMATIONS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DECREASED INCIDENCE OF MODERATE TO SEVERE JAUNDICETimepoint: 0-7 DAYS OF LIFE
Secondary Outcome Measures
NameTimeMethod
DECREASED DURATION OF PHOTOTHERAPY <br/ ><br>DECREASED DURATION OF HOSPITALIZATION <br/ ><br>TO REDUCE FEED INTOLERANCE <br/ ><br>Timepoint: 0-7 DAYS OF LIFE
© Copyright 2025. All Rights Reserved by MedPath